JPMorgan Sees 78% Upside in SpaceX as Grok AI and Orbital Data Centers Accelerate Ambitions
JPMorgan keeps SpaceX Overweight with $240 target. Analyst highlights Grok advances, Cursor deal, Louisiana Starbase, and orbital data centers.
NOTRELOAD AI
McKesson Buys Maryland CRO Precision Medicine Group in $2.25 Billion Deal
Morgan Stanley calls McKesson’s $2.25B Precision Medicine buy a logical CRO addition unlocking a $25B oncology market.
Rezolve Ai Wins Major Google Cloud Deal for Blockchain Data Platform
Google chooses Rezolve Ai technology for indexing and data pipelines in Cloud Web3. Stock rises as AI infrastructure opportunity grows.
Kura Oncology Chairman and CEO Acquires Additional Company Shares
Kura Oncology CEO Troy Wilson purchased 100,000 shares at a $12.39 weighted average price. This follows a similar buy one week earlier, increasing his direct and trust holdings.
Buyers Circle Warner Bros. Assets as Paramount Deal Faces Court Delays
Bankers discuss possible sales of New Line Cinema and Warner Bros. cable networks while Paramount’s $110B WBD takeover faces ongoing antitrust lawsuits.
Agomab: Piper Sandler Sees 368% Upside on Ontunisertib for Fibrostenotic Crohn’s
Agomab trades at a deep discount to Sarepta and Abivax. Piper Sandler starts at Overweight with $60 PT.